Hyperglycemia also modulates some important bone turnover biomarkers such as bone morphogenetic protein-2 (BMP-2), which promotes osteoblast differentiation, and sclerostin, which retard bone formation (9–11). The gene discussed is SOST; the disease is Hyperglycemia.